“During his Senate confirmation hearing in April 2017, Dr. Scott Gottlieb committed himself to “the gold standard of safety and efficacy.”
Over the past two years as head of the Food and Drug Administration (FDA), Commissioner Gottlieb has made good on that promise, and his tenure has been a model for future FDA chiefs.
To his great credit and the benefit of consumers, Gottlieb, whose tenure at the agency ended recently, pursued policies that encouraged competition and choice.
In fall 2016, months before his appointment as FDA chief, Gottlieb foreshadowed his approach to the FDA in testimony at a Senate hearing on the EpiPen price scandal.”
Former White House Director of Legislative Affairs Marc Short joined MSNBC to share his insights on the Republican Party’s evolving stance on tax policy. He…
In today’s episode of Harder to Breathe, host Ryan Dusick, founding drummer of Maroon 5 and licensed therapist, teams up with actor Brian “Duck” Maillard…
How does our relationship with nature affect our health, for better and worse? Dr. Sanjay Gupta explores this idea by pulling from personal experience as…